Trial Profile
Phase Ib/II trial of ETS 2101 [dexanabinol] for various cancer types
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 13 Feb 2013
Price :
$35
*
At a glance
- Drugs Dexanabinol (Primary)
- Indications Cancer; Solid tumours
- Focus Therapeutic Use
- Sponsors e-Therapeutics
- 13 Feb 2013 New trial record